These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24927059)

  • 1. Multivalent agents containing 1-substituted 2,3,4-trihydroxyphenyl moieties as novel synthetic polyphenols directed against HIV-1.
    Flores A; Camarasa MJ; Pérez-Pérez MJ; San-Félix A; Balzarini J; Quesada E
    Org Biomol Chem; 2014 Jul; 12(28):5278-94. PubMed ID: 24927059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
    Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
    Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
    Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
    Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Zhan P; Liu H; Li D; Wang L; Chen X; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Sep; 20(18):5527-36. PubMed ID: 22883027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
    Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
    J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
    Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
    Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitors.
    Liu Y; Meng G; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
    Eur J Pharm Sci; 2014 Oct; 62():334-41. PubMed ID: 24956462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
    Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E
    J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
    Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
    Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
    Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
    Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
    Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones.
    Rao A; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
    Farmaco; 2003 Feb; 58(2):115-20. PubMed ID: 12581777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
    Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
    J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.